Novavax Inc
NVAX
$9.75+0.17 (+1.77%)
Aug 18, 2025, 3:26 PM
Financials
| 52Week High | 15.22 | 52Week Low | 5.01 |
| Beta | 2.84 | Current Ratio Annual | 0.98 |
| Current Ratio Quarterly | 2.36 | Gross Margin TTM | 88.30 |
| Market Cap | 1.66B | Net Profit Margin TTM | 39.20 |
| Operating Margin TTM | 32.58 | Price To Book | 44.04 |
| Price To Earnings TTM | 3.92 | Price To Free Cash Flow TTM | 5.32 |
| Price To Sales TTM | 1.54 | Quick Ratio Annual | 0.92 |
| Quick Ratio Quarterly | 2.18 | Return On Assets TTM | 28.65 |
| Return On Equity TTM | 283.08 | Return On Investment TTM | 40.02 |
| Revenue Growth3Y | -15.89 | Revenue Growth5Y | 105.31 |
| Revenue Growth Quarterly Yoy | -42.42 | Revenue Growth TTMYoy | 9.22 |
| Revenue Per Share TTM | 6.09 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 243 | 1 | 2 | 5 | 7 | 0 | 116.70M | $914.75M |
| Mar 31, 2025 | 249(+2%) | 47(+4600%) | 41(+1950%) | 67(+1240%) | 73(+943%) | 55(+%) | 110.79M(-5%) | $696.64M(-24%) |
| Jun 30, 2025 | 255(+2%) | 38(-19%) | 41 | 86(+28%) | 51(-30%) | 63(+15%) | 115.87M(+5%) | $709.16M(+2%) |